Related Experiment Video

Updated: Oct 5, 2026

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions

M Rassu1, S Cazzavillan, M Scagnelli

  • 1Department of Microbiology, S. Bortolo Hospital, Via Rodolfi 37, 36100 Vicenza, Italy. microbvi@tin.it

Atherosclerosis
|August 14, 2001
PubMed

Insights

Chlamydia pneumoniae (CP) is strongly associated with atherosclerosis across multiple vascular sites. This study found CP in 100% of patients, suggesting its significant role in the disease.

Area of Science:

  • Cardiovascular Research
  • Infectious Disease Pathology
  • Atherosclerosis Etiology

Background:

  • Chlamydia pneumoniae (CP) is implicated in atherosclerosis, but its distribution in various vascular regions remains unclear.
  • Most research focuses on coronary artery disease, leaving other atherosclerotic sites understudied regarding CP presence.

Purpose of the Study:

  • To investigate the prevalence of Chlamydia pneumoniae (CP) in atheromatous plaques from five distinct vascular areas.
  • To determine the association of CP with atherosclerotic disorders across the basilary artery, coronary artery, thoracic aorta, abdominal aorta, and renal arteries.
  • To compare the presence of CP with other suspected atherosclerosis agents, Helicobacter pylori (HP) and cytomegalovirus (CMV).

Main Methods:

  • Nested polymerase chain reaction (PCR) and immunohistochemical staining (IHC) were employed to detect CP in plaque samples.
  • PCR techniques were also used to identify the presence of Helicobacter pylori (HP) and cytomegalovirus (CMV).
  • Plaques were analyzed from five different vascular territories: basilary artery, coronary artery, thoracic aorta, abdominal aorta, and renal arteries.

Main Results:

  • Chlamydia pneumoniae (CP) was detected in 100% of the analyzed atheromatous plaques across all five vascular areas.
  • Helicobacter pylori (HP) was found in 22.2% of patients, and cytomegalovirus (CMV) in 16.6% of patients.
  • The high prevalence of CP across multiple vascular sites suggests a strong link to atherosclerotic disease.

Conclusions:

  • The findings strongly support a significant association between Chlamydia pneumoniae (CP) and atherosclerosis.
  • CP is consistently present in atheromatous plaques from diverse vascular regions, underscoring its role in the disease.
  • Routine detection of CP in multiple vascular areas of patients with atherosclerosis is recommended.

More Related Videos

Quantification of Atherosclerosis in Mice06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis09:55

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

Published on: October 25, 2024

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...